Stock Taper
AGL
AGILON HEALTH, INC.
NYSE
$83.67
▼ DOWN 0.56% (-0.47)

KEY STATISTICS

Market Cap$1.40 B
52w High$133.04
52w Low$7.48
Dividend Yield5.81%
FrequencyQuarterly
P/E-5.43
Volume35.22K
Shares Out.16.68M

COMPANY

LEADERSHIP

Timothy O'Rourke
CHIEF EXECUTIVE
Timothy O'Rourke

COMPENSATION 2026

Salary$431,507
Stock Awards$4,050,004
Incentive Plan Pay$0
All Other Comp.$546,875
Total$7,278,387

ABOUT

SECTOR
Healthcare
WENT PUBLIC
April 15, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
856

PRICE TARGET

Target High$146.00
Target Low$16.00
Target Median$112.00
Target Consensus$94.22

UPCOMING EARNINGS

DateNov 3, 2026
DayTuesday
Rev. Est.$1.46B
NOV
3
TUE

SPLIT RECORD

DATETYPERATIO
2026-03-31Reverse1:25

ETFS HOLDING THIS STOCK

ETFS HOLDING
113
LISTED HERE
10
RANKED BY POSITION SIZE

INSTITUTIONAL OWNERSHIP

SHARES OWNED
100.00%
HOLDERS
311
TOP 8 OF 311 · RANKED BY POSITION SIZE

PRICE

$83.67 ▼ DOWN 0.56% (−$0.47)
OVERLAYS
$83.00$84.00$85.00$86.009:32 AM9:51 AM10:11 AM10:30 AM10:50 AM11:09 AM11:29 AM83.67

About Agilon Health, Inc.

https://agilonhealth.com ↗

agilon health, inc. provides primary care services for seniors in the U.S., serving around 238,000 members—including Medicare Advantage and fee-for-service beneficiaries—as of 2021.

INDUSTRY

Medical - Care Facilities

A SERVICE AGILON HEALTH, INC. IS KNOWN FOR

agilon health Total Care Model Platform

A unified platform enabling primary-care physicians to transition to value-based care for seniors by integrating technology, people, capital, and processes to improve outcomes and reduce costs within Medicare.

Agilon Health in 2025

SENTIMENT: − NEGATIVE
Ronald A. Williams
LEADERSHIP · AUGUST 2025

Agilon Health CEO Steps Down Amid Disappointing Q2 Results and Withdrawal of 2025 Guidance, Triggering Stock Collapse and Legal Scrutiny

On August 4, 2025, Agilon Health announced the immediate departure of President and CEO Steven Sell. The announcement coincided with the release of poor second-quarter financial results, including a net loss of $104 million, and the withdrawal of its full-year 2025 earnings guidance, citing the leadership transition and market uncertainties. This confluence of negative news sent the company's stock price plummeting by over 50% and prompted numerous law firms to launch investigations and file securities fraud class-action lawsuits on behalf of investors.

RESTRUCTURING · Q2 AND Q3 2025 · IN PROGRESS

Agilon Health Pivots from Rapid Growth to Profitability with Market Exits, Cost Reductions, and Leadership Change

In 2025, Agilon Health initiated a significant strategic shift away from rapid membership growth towards a focus on profitability and operational efficiency. This multi-faceted restructuring involves exiting unprofitable markets and payer contracts, implementing cost-cutting measures, and a change in executive leadership to steer the company towards a more sustainable financial future.

Latest News

BUSINESS WIRE · SEP 30, 2026

agilon health and The Jackson Clinic Advance Their Partnership Through Senior Health Connect ACO

WESTERVILLE, Ohio.--(BUSINESS WIRE)--agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced the expansion of its partnership with The Jackson Clinic, which will join one of agilon's Senior Health Connect Accountable Care Organizations (ACOs). The Jackson Clinic, one of Tennessee's largest independent physician organizations, includes more than 130 providers representing 24 specialties and subspecialties at 13 locations s.

RATINGS SNAPSHOT

Overall rating: D+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book1
Overall Score1

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 3
NEUTRAL 2
HOLD 2
OUTPERFORM 1
UNDERWEIGHT 1
OVERWEIGHT 1
EQUAL WEIGHT 1
IN LINE 1
12 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
ANNX$4.19COMPARE
SOPH$8.07COMPARE
SLP$18.50COMPARE
LRMR$2.96COMPARE
DBVT$10.55COMPARE
NAKA$9.66COMPARE
ENGN$1.94COMPARE
DH$0.93COMPARE

INSIDER TRADES

★
OFFICER: CHIEF ACCOUNTING OFFICER
Gertsch Timothy
Sale · 17 shares
2026-08-16
★
OFFICER: CHIEF LEGAL OFFICER
Zamore Denise
Sale · 37 shares
2026-08-01
★
OFFICER: CHIEF FINANCIAL OFFICER
Schwaneke Jeffrey A.
Sale · 2.3K shares
2026-07-01
★
OFFICER: CHIEF LEGAL OFFICER
Zamore Denise
Sale · 485 shares
2026-06-01